Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Itami

Showing results (171-180 of 227) with videos related to

Pageof 23
Sort By:
Journal of Radiation Research|December 12, 2019
Prognostic impact of immunohistopathologic features in definitive radiation therapy for nasopharyngeal cancer patientsNaoya Murakami, Taisuke Mori, Yuko Kubo, et al.
Cancer Medicine|December 4, 2019
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapyYoshitaka Honma, Kengo Nagashima, Hidekazu Hirano, et al.
Investigational New Drugs|September 17, 2020
Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinomaShigemasa Takamizawa, Yoshitaka Honma, Naoya Murakami, et al.
Radiation Oncology (London, England)|July 31, 2019
Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402)Hiroyuki Okamoto, Naoya Murakami, Fumiaki Isohashi, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 19, 2025
Transcriptome analysis of human oral squamous cancer SAS cells as an early response after boron neutron capture therapyShoji Imamichi, Tasuku Ito, Ying Tong, et al.
Scientific Reports|September 29, 2021
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancerIkumi Kuno, Daisuke Takayanagi, Yuka Asami, et al.
Technology in Cancer Research & Treatment|February 2, 2013
Acute radiation esophagitis caused by high-dose involved field radiotherapy with concurrent cisplatin and vinorelbine for stage III non-small cell lung cancerYuuki Kuroda, Ikuo Sekine, Minako Sumi, et al.
Journal of Radiation Research|April 6, 2021
Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancerKoji Inaba, Keisuke Tsuchida, Tairo Kashihara, et al.
Cancer Medicine|August 5, 2020
Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancerKeisuke Tsuchida, Koji Inaba, Tairo Kashihara, et al.
BMC Cancer|March 9, 2016
Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinomaNaoya Murakami, Fumihiko Matsumoto, Seiichi Yoshimoto, et al.
Pageof 23

Showing results (171-180 of 227) with videos related to

Sort By:
Pageof 23
Journal of Radiation Research|December 12, 2019
Prognostic impact of immunohistopathologic features in definitive radiation therapy for nasopharyngeal cancer patientsNaoya Murakami, Taisuke Mori, Yuko Kubo, et al.
Cancer Medicine|December 4, 2019
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapyYoshitaka Honma, Kengo Nagashima, Hidekazu Hirano, et al.
Investigational New Drugs|September 17, 2020
Short-term outcomes of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (TPF) in locally advanced nasopharyngeal carcinomaShigemasa Takamizawa, Yoshitaka Honma, Naoya Murakami, et al.
Radiation Oncology (London, England)|July 31, 2019
Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402)Hiroyuki Okamoto, Naoya Murakami, Fumiaki Isohashi, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|January 19, 2025
Transcriptome analysis of human oral squamous cancer SAS cells as an early response after boron neutron capture therapyShoji Imamichi, Tasuku Ito, Ying Tong, et al.
Scientific Reports|September 29, 2021
TP53 mutants and non-HPV16/18 genotypes are poor prognostic factors for concurrent chemoradiotherapy in locally advanced cervical cancerIkumi Kuno, Daisuke Takayanagi, Yuka Asami, et al.
Technology in Cancer Research & Treatment|February 2, 2013
Acute radiation esophagitis caused by high-dose involved field radiotherapy with concurrent cisplatin and vinorelbine for stage III non-small cell lung cancerYuuki Kuroda, Ikuo Sekine, Minako Sumi, et al.
Journal of Radiation Research|April 6, 2021
Treatment results of radiotherapy to both the prostate and metastatic sites in patients with bone metastatic prostate cancerKoji Inaba, Keisuke Tsuchida, Tairo Kashihara, et al.
Cancer Medicine|August 5, 2020
Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancerKeisuke Tsuchida, Koji Inaba, Tairo Kashihara, et al.
BMC Cancer|March 9, 2016
Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinomaNaoya Murakami, Fumihiko Matsumoto, Seiichi Yoshimoto, et al.
Pageof 23